KR20140081694A - Phenophosphazines compounds - Google Patents
Phenophosphazines compounds Download PDFInfo
- Publication number
- KR20140081694A KR20140081694A KR1020130157818A KR20130157818A KR20140081694A KR 20140081694 A KR20140081694 A KR 20140081694A KR 1020130157818 A KR1020130157818 A KR 1020130157818A KR 20130157818 A KR20130157818 A KR 20130157818A KR 20140081694 A KR20140081694 A KR 20140081694A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- substituted
- composition
- alkyl
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 claims abstract description 37
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 27
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 27
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 22
- 125000001072 heteroaryl group Chemical group 0.000 claims description 20
- 125000003118 aryl group Chemical group 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 8
- 125000003107 substituted aryl group Chemical group 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000126 substance Substances 0.000 abstract description 4
- 239000010410 layer Substances 0.000 description 16
- -1 1-fluorenyl Chemical group 0.000 description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 125000005842 heteroatom Chemical group 0.000 description 6
- 238000004770 highest occupied molecular orbital Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 5
- 150000004982 aromatic amines Chemical group 0.000 description 5
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 0 Cc(cc1)ccc1N1c(ccc(*)c2)c2P(C2C=CC=CC2)c2c1ccc(*)c2 Chemical compound Cc(cc1)ccc1N1c(ccc(*)c2)c2P(C2C=CC=CC2)c2c1ccc(*)c2 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 230000005525 hole transport Effects 0.000 description 4
- IMKMFBIYHXBKRX-UHFFFAOYSA-M lithium;quinoline-2-carboxylate Chemical group [Li+].C1=CC=CC2=NC(C(=O)[O-])=CC=C21 IMKMFBIYHXBKRX-UHFFFAOYSA-M 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- DSXXFIGDMLEEQZ-UHFFFAOYSA-N 2-bromo-n-(2-bromophenyl)-n-phenylaniline Chemical class BrC1=CC=CC=C1N(C=1C(=CC=CC=1)Br)C1=CC=CC=C1 DSXXFIGDMLEEQZ-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- ARRNBPCNZJXHRJ-UHFFFAOYSA-M hydron;tetrabutylazanium;phosphate Chemical compound OP(O)([O-])=O.CCCC[N+](CCCC)(CCCC)CCCC ARRNBPCNZJXHRJ-UHFFFAOYSA-M 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 238000000859 sublimation Methods 0.000 description 3
- 230000008022 sublimation Effects 0.000 description 3
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 description 2
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000003775 Density Functional Theory Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 150000001204 N-oxides Chemical class 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 2
- 125000005104 aryl silyl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000000607 proton-decoupled 31P nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 150000003839 salts Chemical group 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000003115 supporting electrolyte Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 125000005259 triarylamine group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UHOVQNZJYSORNB-RALIUCGRSA-N 1,2,3,4,5-pentadeuteriobenzene Chemical compound [2H]C1=CC([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-RALIUCGRSA-N 0.000 description 1
- MNCMBBIFTVWHIP-UHFFFAOYSA-N 1-anthracen-9-yl-2,2,2-trifluoroethanone Chemical group C1=CC=C2C(C(=O)C(F)(F)F)=C(C=CC=C3)C3=CC2=C1 MNCMBBIFTVWHIP-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- QRLKFLMGQFSNAP-UHFFFAOYSA-N 2-bromo-N-(2-bromo-4-methylphenyl)-4-methyl-N-(4-methylphenyl)aniline Chemical compound BrC1=C(N(C2=CC=C(C=C2)C)C2=C(C=C(C=C2)C)Br)C=CC(=C1)C QRLKFLMGQFSNAP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- LPPOLXWWGHVVJI-UHFFFAOYSA-N 4-dichlorophosphanyl-N,N-diphenylaniline Chemical compound ClP(C1=CC=C(N(C2=CC=CC=C2)C2=CC=CC=C2)C=C1)Cl LPPOLXWWGHVVJI-UHFFFAOYSA-N 0.000 description 1
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000004057 DFT-B3LYP calculation Methods 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 125000002078 anthracen-1-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C([*])=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 125000000748 anthracen-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C([H])=C([*])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005199 aryl carbonyloxy group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000005284 basis set Methods 0.000 description 1
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 1
- AQHMSOCWYFWQRO-UHFFFAOYSA-N benzene;methylsulfinylmethane Chemical compound CS(C)=O.C1=CC=CC=C1 AQHMSOCWYFWQRO-UHFFFAOYSA-N 0.000 description 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 150000001602 bicycloalkyls Chemical group 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 150000001975 deuterium Chemical group 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- JROGBPMEKVAPEH-GXGBFOEMSA-N emetine dihydrochloride Chemical compound Cl.Cl.N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC JROGBPMEKVAPEH-GXGBFOEMSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 125000003914 fluoranthenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC=C4C1=C23)* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000012585 nuclear overhauser effect spectroscopy experiment Methods 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 150000005033 phenoxaphosphines Chemical class 0.000 description 1
- OEHGHDIVTXNSJU-UHFFFAOYSA-N phenoxaphosphinine 10-oxide Chemical class C1=CC=CC=2OC3=CC=CC=C3P(C1=2)=O OEHGHDIVTXNSJU-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000001935 tetracenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000006822 tri(C1-C30) alkylsilyl group Chemical group 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 1
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/188—Metal complexes of other metals not provided for in one of the previous groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/549—Organic PV cells
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Electroluminescent Light Sources (AREA)
- Plural Heterocyclic Compounds (AREA)
- Photovoltaic Devices (AREA)
Abstract
Description
유기 발광 장치(OLED)는 전계발광 층으로서 유기 방향족 화합물을 함유한 필름 스택(stack)을 채용한 디스플레이 장치이다. 이러한 화합물은 일반적으로 전계발광 재료 및 전하 수송 재료로 분류된다. 이러한 전계발광 화합물 및 전하 수송 화합물에 필요한 몇 가지 특징은 고체 상태에서의 높은 형광 양자 수율, 전자 및 정공의 높은 이동성, 진공에서 증착하는 동안의 화학적 안정성, 및 안정된 필름을 형성하는 능력을 포함한다.The organic light emitting device OLED is a display device employing a film stack containing an organic aromatic compound as an electroluminescent layer. Such a compound is generally classified into an electroluminescent material and a charge transporting material. Some characteristics required for such electroluminescent compounds and charge transport compounds include high fluorescence quantum yields in the solid state, high mobility of electrons and holes, chemical stability during deposition in vacuum, and the ability to form stable films.
OLED의 통상적인 문제는 빠른 노화/짧은 수명, 바람직하지 않게 높은 작동 전압, 또는 부족한 효율을 포함한다. 유기 발광 다이오드(OLED)의 전자 수송 층(ETL) 및 정공 수송 층(HTL)을 위한 새로운 재료의 발견은 장치 성능 및 수명의 향상을 목적으로 해왔다. HTL 층의 경우, 최신 기술은 많은 현재의 발광 및 인광 OLED 설계를 만족시키는 트리아릴아민-기재 재료를 사용한다. 인광 OLED 설계에서, 장치 효율, 수명, 및 휘도는 여전히 청색 인광 OLED의 대량 생산을 위한 이슈로서 남아 있다. Common problems with OLEDs include fast aging / short lifetime, undesirably high operating voltage, or poor efficiency. The discovery of new materials for the electron transport layer (ETL) and the hole transport layer (HTL) of organic light emitting diodes (OLEDs) has been aimed at improving device performance and lifetime. In the case of the HTL layer, the state of the art uses triarylamine-based materials that satisfy many current emission and phosphorescent OLED designs. In phosphorescent OLED designs, device efficiency, lifetime, and luminance still remain issues for the mass production of blue phosphorescent OLEDs.
따라서, 현재의 기술에 비해 강화된 특성들을 보유한 정공 수송 층이 필요하다. 추가로, 전하를 방출 층으로 더 빠르게 수송하며 오래 지속되고 효율이 높은 장치를 가능하게 하는 정공 수송 재료도 필요하다. 이러한 요구 등은 하기 발명에 의해 충족된다.Therefore, there is a need for a hole transport layer having enhanced properties compared to current technologies. In addition, there is a need for hole transport materials that enable faster transport of charge to the emissive layer and long lasting and efficient devices. These requirements and the like are satisfied by the following invention.
본 발명은 하기 화합물에서 선택된 1종 이상의 화합물을 포함하는 조성물을 제공한다:The present invention provides compositions comprising at least one compound selected from the following compounds:
A) A)
(여기에서, 화학식 A 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소 또는 치환된 탄화수소이고,Wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 are each independently a hydrocarbon or a substituted hydrocarbon,
여기에서, 선택적으로 R2, R3, R4, R5, R6, R7, R8, R9 및 R10에서 선택된 2개 이상의 R 기는 1개 이상의 고리 구조를 형성할 수 있음);Wherein two or more R groups optionally selected from R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 may form one or more ring structures;
B)B)
(여기에서, 화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소 또는 치환된 탄화수소이고,(Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are each independently a hydrocarbon or a substituted hydrocarbon,
여기에서, 선택적으로 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10에서 선택된 2개 이상의 R 기는 1개 이상의 고리 구조를 형성할 수 있음); 또는Wherein two or more R groups optionally selected from R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 may form one or more ring structures; or
C) 이들의 조합.C) a combination of these.
중심 페노포스파진 코어에 기초한 새로운 부류의 분자가 발견되었다. 이러한 분자는 1) 인 중심 또는 페노포스파진 코어 상에 위치하는 유기 기의 조절, 및 2) 인 중심의 산화 상태를 통해 조작될 수 있다. 이러한 유도체들의 컴퓨터 모델링은 이러한 화합물로 된 전하 수송 층이 더 높은 삼중항 에너지를 소유하면서, 바람직한 HOMO 및 LUMO 에너지 준위를 유지함을 시사한다. 또한, R2, R3, R4, R5, R6, R7, R8, R9 및 R10 위치에서의 아릴아민 치환은 HOMO 오비탈을 이러한 치환기가 위치한 벤젠 고리를 가로질러 비편재화시킨다. 결과적으로, OLED 장치에 형성된 여기자(exciton)는 방출 층으로 잘 제한되며, 향상된 장치 휘도, 수명, 및 효율을 가져온다.A new class of molecules based on the central phenophosphine core has been discovered. Such molecules can be manipulated through the regulation of organic groups located on 1) the center or on the phenophosphazene core, and 2) the oxidation state of phosphorus centers. Computer modeling of these derivatives suggests that the charge transport layer of such compounds retains the higher HOMO and LUMO energy levels, while retaining higher triplet energies. Also, arylamine substitution at the R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9, and R 10 positions delineate the HOMO orbitals across the benzene ring on which these substituents are located . As a result, the excitons formed in OLED devices are well confined to the emissive layer, resulting in improved device brightness, lifetime, and efficiency.
위에서 논의된 바와 같이, 본 발명은 하기 화합물에서 선택된 1종 이상의 화합물을 포함하는 조성물을 제공한다:As discussed above, the present invention provides compositions comprising at least one compound selected from the following compounds:
A)A)
(여기에서, 화학식 A 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소(H 포함), 또는 치환된 탄화수소이고,Wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 in the formula (A) are each independently hydrocarbons (including H), or substituted hydrocarbons,
여기에서, 선택적으로 R2, R3, R4, R5, R6, R7, R8, R9 및 R10에서 선택된 2개 이상의 R 기는 1개 이상의 고리 구조를 형성할 수 있음);Wherein two or more R groups optionally selected from R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 may form one or more ring structures;
B)B)
(여기에서, 화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소(H 포함), 또는 치환된 탄화수소이고,Wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 are independently hydrocarbons (including H) or substituted hydrocarbons,
여기에서, 선택적으로 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10에서 선택된 2개 이상의 R 기는 1개 이상의 고리 구조를 형성할 수 있음); 또는Wherein two or more R groups optionally selected from R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 may form one or more ring structures; or
C) 이들의 조합.C) a combination of these.
본 발명의 조성물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compositions of the present invention may comprise a combination of two or more of the embodiments described herein.
본원에 사용된 R1 = R1, R2 = R2, R3 = R3 ... 이다.Is used herein R1 = R 1, R2 = R 2, R3 = R 3 ....
한 실시양태에서, 화학식 A 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 탄화수소 또는 치환된 탄화수소이고, In one embodiment, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 in formula A are each a hydrocarbon or substituted hydrocarbon,
화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소 또는 치환된 탄화수소이다.R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 are each independently a hydrocarbon or a substituted hydrocarbon.
한 실시양태에서, 화학식 A 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 수소, 알킬, 치환된 알킬, 아릴, 치환된 아릴, 헤테로아릴, 또는 치환된 헤테로아릴이고,In one embodiment, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 in formula A are each independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, Lt; / RTI >
여기에서, 화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 수소, 알킬, 치환된 알킬, 아릴, 치환된 아릴, 헤테로아릴, 또는 치환된 헤테로아릴이다.Wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 are each independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, / RTI >
한 실시양태에서, 화학식 A 중 R2, R4, R5, R6, R7 및 R9는 각각 수소이고, 화학식 B 중 R2, R4, R5, R6, R7 및 R9는 각각 수소이다.In one embodiment, R2, R4, R5, R6, R7 and R9 in formula A are each hydrogen and R2, R4, R5, R6, R7 and R9 in formula B are each hydrogen.
한 실시양태에서, 화학식 A 중 R3 및 R8은 각각 독립적으로 알킬, 더 바람직하게는 C1 내지 C8 알킬, 더 바람직하게는 C1 내지 C4 알킬, 더 바람직하게는 에틸 또는 메틸이고, 화학식 B 중 R3 및 R8은 각각 독립적으로 알킬, 더 바람직하게는 C1 내지 C8 알킬, 더 바람직하게는 C1 내지 C4 알킬, 더 바람직하게는 에틸 또는 메틸이다.In one embodiment, R3 and R8 in formula A are each independently alkyl, more preferably C1 to C8 alkyl, more preferably C1 to C4 alkyl, more preferably ethyl or methyl, and R3 and R8 in formula Are each independently alkyl, more preferably C1 to C8 alkyl, more preferably C1 to C4 alkyl, more preferably ethyl or methyl.
한 실시양태에서, 화학식 A 중 R2, R3, R4, R5, R6, R7, R8, R9 및 R10 중의 하나 이상은 아릴아민이고, 화학식 B 중 R2, R3, R4, R5, R6, R7, R8, R9 및 R10 중의 하나 이상은 아릴아민이다.In one embodiment, at least one of R2, R3, R4, R5, R6, R7, R8, R9 and R10 in Formula A is an arylamine and R2, R3, R4, R5, R6, At least one of R < 9 > and R < 10 > is an arylamine.
한 실시양태에서, 화학식 A 중 R1은 6개 이상의 탄소 원자를 포함하며, 여기에서 화학식 B 중 R1은 6개 이상의 탄소 원자를 포함한다.In one embodiment, R1 in formula (A) comprises 6 or more carbon atoms, wherein R1 in formula (B) comprises 6 or more carbon atoms.
한 실시양태에서, 화학식 A 중 R10은 6개 이상의 탄소 원자를 함유하며, 여기에서 화학식 B 중 R10은 6개 이상의 탄소 원자를 포함한다.In one embodiment, R10 in formula A contains at least 6 carbon atoms, wherein R10 in formula B comprises at least 6 carbon atoms.
한 실시양태에서, 조성물은 화학식 A의 화합물 및 화학식 B의 화합물을 포함한다.In one embodiment, the composition comprises a compound of formula (A) and a compound of formula (B).
한 실시양태에서, 1종 이상의 화합물은 하기 화합물, 또는 이들의 조합에서 선택된다.In one embodiment, the at least one compound is selected from the following compounds, or combinations thereof.
, , , , , ,
한 실시양태에서, 1종 이상의 화합물은 화학식 A에서 선택된다.In one embodiment, at least one compound is selected from formula (A).
한 실시양태에서, 화학식 A 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소 또는 치환된 탄화수소이다.In one embodiment, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 in formula (A) are each independently a hydrocarbon or a substituted hydrocarbon.
한 실시양태에서, 화학식 A 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 수소, 알킬, 치환된 알킬, 아릴, 치환된 아릴, 헤테로아릴, 또는 치환된 헤테로아릴이다.In one embodiment, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 in formula A are each independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, Lt; / RTI >
한 실시양태에서, 화학식 A 중 R2, R4, R5, R6, R7 및 R9는 각각 수소이다.In one embodiment, R2, R4, R5, R6, R7 and R9 in formula (A) are each hydrogen.
한 실시양태에서, 화학식 A 중 R3 및 R8은 각각 독립적으로 알킬, 더 바람직하게는 C1 내지 C8 알킬, 더 바람직하게는 C1 내지 C4 알킬, 더 바람직하게는 에틸 또는 메틸이다.In one embodiment, R3 and R8 in formula A are each independently alkyl, more preferably C1 to C8 alkyl, more preferably C1 to C4 alkyl, more preferably ethyl or methyl.
한 실시양태에서, 화학식 A 중 R2, R3, R4, R5, R6, R7, R8, R9 및 R10 중의 하나 이상은 아릴아민이다.In one embodiment, at least one of R2, R3, R4, R5, R6, R7, R8, R9 and R10 in formula (A) is an arylamine.
한 실시양태에서, 화학식 A 중 R1은 6개 이상의 탄소 원자를 포함한다.In one embodiment, R1 in formula A comprises at least 6 carbon atoms.
한 실시양태에서, 화학식 A 중 R1은 1개 이상의 산소 원자 또는 1개 이상의 질소 원자를 추가로 포함한다.In one embodiment, R1 in formula (A) further comprises at least one oxygen atom or at least one nitrogen atom.
한 실시양태에서, 화학식 A 중 R1은 12개 이상의 탄소 원자를 추가로 포함한다.In one embodiment, R1 in formula A further comprises at least 12 carbon atoms.
한 실시양태에서, 화학식 A 중, R10은 6개 이상의 탄소 원자를 포함한다.In one embodiment, in formula A, R10 comprises 6 or more carbon atoms.
한 실시양태에서, 1종 이상의 화합물은 하기 화합물에서 선택된다.In one embodiment, the at least one compound is selected from the following compounds.
, ,
한 실시양태에서, 1종 이상의 화합물은 하기 화합물이다.In one embodiment, the one or more compounds are the following compounds.
화학식 A의 화합물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compounds of formula (A) may comprise a combination of two or more of the embodiments described herein.
한 실시양태에서, 1종 이상의 화합물은 화학식 B에서 선택된다.In one embodiment, at least one compound is selected in formula (B).
한 실시양태에서, 화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소 또는 치환된 탄화수소이다.In one embodiment, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 in Formula B are each independently a hydrocarbon or a substituted hydrocarbon.
한 실시양태에서, 화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 수소, 알킬, 치환된 알킬, 아릴, 치환된 아릴, 헤테로아릴, 또는 치환된 헤테로아릴이다.In one embodiment, R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 in Formula B are each independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, Lt; / RTI >
한 실시양태에서, 화학식 B 중 R2, R4, R5, R6, R7 및 R9는 각각 수소이다.In one embodiment, R2, R4, R5, R6, R7 and R9 in formula (B) are each hydrogen.
한 실시양태에서, 화학식 B 중 R3 및 R8은 각각 독립적으로 알킬, 더 바람직하게는 C1 내지 C8 알킬, 더 바람직하게는 C1 내지 C4 알킬, 더 바람직하게는 에틸 또는 메틸이다.In one embodiment, R3 and R8 in formula B are each independently alkyl, more preferably C1 to C8 alkyl, more preferably C1 to C4 alkyl, more preferably ethyl or methyl.
한 실시양태에서, 화학식 B 중 R2, R3, R4, R5, R6, R7, R8, R9 및 R10 중의 하나 이상은 아릴아민이다.In one embodiment, at least one of R2, R3, R4, R5, R6, R7, R8, R9 and R10 in Formula B is an arylamine.
한 실시양태에서, 화학식 B 중 R1은 6개 이상의 탄소 원자를 포함한다.In one embodiment, R < 1 > in formula (B) comprises at least 6 carbon atoms.
한 실시양태에서, 화학식 B 중 R1은 1개 이상의 산소 원자 또는 1개 이상의 질소 원자를 추가로 포함한다.In one embodiment, R < 1 > in formula (B) further comprises at least one oxygen atom or at least one nitrogen atom.
한 실시양태에서, 화학식 B 중 R1은 12개 이상의 탄소 원자를 추가로 포함한다.In one embodiment, R < 1 > in formula (B) further comprises at least 12 carbon atoms.
한 실시양태에서, 화학식 B 중 R10은 6개 이상의 탄소 원자를 포함한다.In one embodiment, R < 10 > in formula (B) comprises at least 6 carbon atoms.
한 실시양태에서, 1종 이상의 화합물은 하기 화합물에서 선택된다.In one embodiment, the at least one compound is selected from the following compounds.
, 또는 , or
한 실시양태에서, 1종 이상의 화합물은 하기 화합물이다.In one embodiment, the one or more compounds are the following compounds.
화학식 B의 화합물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compound of formula (B) may comprise a combination of two or more of the embodiments described herein.
한 실시양태에서, 1종 이상의 화합물은 400 g/mol 이상, 더 바람직하게는 500 g/mol 이상의 분자량을 갖는다.In one embodiment, the at least one compound has a molecular weight of at least 400 g / mol, more preferably at least 500 g / mol.
한 실시양태에서, 1종 이상의 화합물은 600 g/mol 이상, 더 바람직하게는 700 g/mol 이상의 분자량을 갖는다.In one embodiment, the at least one compound has a molecular weight of at least 600 g / mol, more preferably at least 700 g / mol.
한 실시양태에서, 1종 이상의 화합물은 -4.7 eV 내지 -5.6 eV의 HOMO 준위를 갖는다.In one embodiment, the at least one compound has a HOMO level of from -4.7 eV to -5.6 eV.
한 실시양태에서, 1종 이상의 화합물은 -1.0 eV 내지 -3.0 eV의 LUMO 준위를 갖는다.In one embodiment, the at least one compound has a LUMO level of -1.0 eV to -3.0 eV.
한 실시양태에서, 1종 이상의 화합물은 2.00 eV 내지 4.00 eV의 삼중항 에너지를 갖는다.In one embodiment, the at least one compound has a triplet energy of 2.00 eV to 4.00 eV.
한 실시양태에서, 1종 이상의 화합물은 200℃ 이상의 승화 온도를 갖는다.In one embodiment, the at least one compound has a sublimation temperature of at least 200 < 0 > C.
한 실시양태에서, 1종 이상의 화합물은 1개 이상의 중수소 원자를 포함한다.In one embodiment, the at least one compound comprises at least one deuterium atom.
본 발명의 화합물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compounds of the present invention may comprise a combination of two or more of the embodiments described herein.
한 실시양태에서, 조성물은 금속 퀴놀레이트를 추가로 포함한다. 추가 실시양태에서, 금속 퀴놀레이트는 리튬 퀴놀레이트이다.In one embodiment, the composition further comprises metal quinolate. In a further embodiment, the metal quinolate is lithium quinolate.
한 실시양태에서, 조성물은 조성물의 중량을 기준으로 10 내지 90 중량%, 더 바람직하게는 10 내지 70 중량%의 금속 퀴놀레이트를 포함한다. 추가 실시양태에서, 조성물은 조성물의 중량을 기준으로 10 내지 50 중량%의 금속 퀴놀레이트를 포함한다. 추가 실시양태에서, 조성물은 조성물의 중량을 기준으로 20 내지 50 중량%의 금속 퀴놀레이트를 포함한다.In one embodiment, the composition comprises 10 to 90 wt%, more preferably 10 to 70 wt% metal quinolate, based on the weight of the composition. In a further embodiment, the composition comprises 10 to 50 wt% metal quinolate, based on the weight of the composition. In a further embodiment, the composition comprises 20 to 50 wt% metal quinolate, based on the weight of the composition.
한 실시양태에서, 조성물은 조성물의 중량을 기준으로 10 내지 90 중량%, 더 바람직하게는 10 내지 70 중량%의 리튬 퀴놀레이트를 함유한다. 추가 실시양태에서, 조성물은 조성물의 중량을 기준으로 10 내지 50 중량%의 리튬 퀴놀레이트를 포함한다. 추가 실시양태에서, 조성물은 조성물의 중량을 기준으로 20 내지 50 중량%의 리튬 퀴놀레이트를 포함한다.In one embodiment, the composition contains 10 to 90 wt%, more preferably 10 to 70 wt%, of lithium quinolate, based on the weight of the composition. In a further embodiment, the composition comprises 10 to 50 weight percent lithium quinolate, based on the weight of the composition. In a further embodiment, the composition comprises 20 to 50 weight percent lithium quinolate, based on the weight of the composition.
본 발명의 조성물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compositions of the present invention may comprise a combination of two or more of the embodiments described herein.
본 발명은 또한 본원에 기재된 1개 이상의 실시양태의 본 발명의 조성물로부터 형성된 1개 이상의 층을 포함하는 필름을 제공한다.The present invention also provides a film comprising at least one layer formed from the composition of the present invention in one or more embodiments described herein.
본 발명은 또한 본원에 기재된 1개 이상의 실시양태의 본 발명의 조성물로부터 형성된 1개 이상의 필름 층을 포함하는 전자 장치를 제공한다.The present invention also provides an electronic device comprising at least one film layer formed from the composition of the present invention in one or more embodiments described herein.
본 발명은 또한 본원에 기재된 1개 이상의 실시양태의 본 발명의 조성물로부터 형성된 1개 이상의 성분을 포함하는 전자 장치를 제공한다.The present invention also provides an electronic device comprising one or more components formed from the composition of the present invention in one or more embodiments described herein.
본 발명의 조성물은 유기 발광 다이오드(OLED), 또는 유기 태양 전지를 포함하는 관련된 유기 전자 장치 응용에 유용하다. 더욱 구체적으로, 본 발명의 조성물은 HIL(정공 주입 층), HTL(정공 수송 층), EML(호스트 및 도펀트를 포함하는 방출 층), ETL(전자 수송 층)을 포함하는 OLED의 개별 층에 응용된다.The compositions of the present invention are useful in related organic electronic device applications, including organic light emitting diodes (OLEDs), or organic solar cells. More specifically, the composition of the present invention is applied to individual layers of OLEDs including HIL (hole injection layer), HTL (hole transport layer), EML (emissive layer including host and dopant), ETL (electron transport layer) do.
본 발명의 필름은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The film of the present invention may comprise a combination of two or more of the embodiments described herein.
본 발명의 장치는 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The apparatus of the present invention may comprise a combination of two or more of the embodiments described herein.
본 발명의 조성물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compositions of the present invention may comprise a combination of two or more of the embodiments described herein.
1종 이상의 화합물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The one or more compounds may comprise a combination of two or more of the embodiments described herein.
화학식 A의 화합물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compounds of formula (A) may comprise a combination of two or more of the embodiments described herein.
화학식 B의 화합물은 본원에 기재된 2개 이상의 실시양태의 조합을 포함할 수 있다.The compound of formula (B) may comprise a combination of two or more of the embodiments described herein.
본 발명의 화합물의 합성은 전형적으로 적절하게 치환된 2-브로모-N-(2-브로모페닐)-N-페닐아닐린의 제조를 필요로 한다. 이러한 분자는 적절하게 치환된 친핵체와 반응하여 목적하는 페노포스파진 종을 생성한다. 원할 경우, 페녹사포스핀 유도체를 H2O2로 산화시켜 치환된 페노포스파진 10-옥사이드를 생성할 수 있다. 치환된 2-브로모-N-(2-브로모페닐)-N-페닐아닐린의 합성은 종래 기술에 따라 상업적으로 입수 가능한 트리아릴아민 및 N-브로모숙신이미드 2 당량을 사용하여 달성될 수 있다. 인-C(아릴) 상호작용성을 갖는 유도체를 생성하기 위해 2-브로모-N-(2-브로모페닐)-N-페닐아닐린을 치환된 이염화포스핀과 반응시켜 목적하는 생성물을 생성한다. 이러한 분자는 추가로 페녹사포스핀 10-옥사이드의 R 치환에 의해 유도체화되어 정공 수송 분자를 생성한다. 예를 들어, 하기 반응식을 보라.The synthesis of the compounds of the present invention typically requires preparation of appropriately substituted 2-bromo-N- (2-bromophenyl) -N-phenylaniline. Such a molecule reacts with an appropriately substituted nucleophile to produce the desired phenophosphazene species. If desired, the phenoxaphosphine derivative can be oxidized with H 2 O 2 to produce the substituted phenophosphazene 10-oxide. Synthesis of substituted 2-bromo-N- (2-bromophenyl) -N-phenylaniline is accomplished using 2 equivalents of commercially available triarylamine and N-bromosuccinimide according to the prior art . 2-bromo-N- (2-bromophenyl) -N-phenylaniline is reacted with a substituted disubstituted canthospin to produce the desired product with a -C (aryl) . These molecules are further derivatized by R substitution of phenoxaphosphine 10-oxide to produce hole-transporting molecules. For example, see the following reaction.
본원에 사용된 용어 "탄화수소"는 오직 탄소와 수소 원자만(H와 C; H; 또는 C) 함유한 화학 기를 지칭한다. 본원에 사용된 용어 "탄화수소"는 수소를 포함한다.The term "hydrocarbon" as used herein refers to a chemical group containing only carbon and hydrogen atoms (H and C; H; or C). The term "hydrocarbon" as used herein includes hydrogen.
본원에 사용된 용어 "치환된 탄화수소"는 1개 이상의 수소가 독립적으로 1개 이상의 헤테로원자를 포함하는 다른 기로 치환되고/거나 1개 이상의 탄소가 독립적으로 1개 이상의 헤테로 원자를 포함하는 다른 기로 치환된 탄화수소를 지칭한다.The term "substituted hydrocarbons" as used herein refers to an aromatic hydrocarbon group in which one or more hydrogens are independently substituted with another group containing one or more heteroatoms and / or one or more carbons are independently substituted with another group containing one or more heteroatoms ≪ / RTI >
본원에 사용된 용어 "아릴"은 방향족 탄화수소로부터 유도된 유기 기를 나타낸다. 아릴 기는 모노시클릭 및/또는 융합된 고리 구조일 수 있으며, 각각의 고리는 4개 내지 7개, 바람직하게는 5개 또는 6개의 시클릭 원자를 적절하게 함유할 수 있다. 또한 2개 이상의 아릴 기가 단일 결합을 통해 결합된 구조도 포함된다. 구체적인 예들은 페닐, 나프틸, 비페닐, 안트릴, 인데닐, 플루오레닐, 페난트릴, 트리페닐레닐, 피레닐, 페릴레닐, 크리세닐, 나프타세닐, 플루오란테닐 등을 포함하나 이에 한정되지 않는다. 나프닐은 1-나프닐 또는 2-나프틸일 수 있으며, 안트릴은 1-안트릴, 2-안트릴 또는 9-안트릴일 수 있고, 플루오레닐은 1-플루오레닐, 2-플루오레닐, 3-플루오레닐, 4-플루오레닐 및 9-플루오레닐 중 어느 하나일 수 있다.The term "aryl" as used herein refers to an organic group derived from an aromatic hydrocarbon. The aryl group may be monocyclic and / or fused ring structures, and each ring may suitably contain from 4 to 7, preferably 5 or 6, cyclic atoms. Also included is a structure in which two or more aryl groups are bonded through a single bond. Specific examples include but are not limited to phenyl, naphthyl, biphenyl, anthryl, indenyl, fluorenyl, phenanthryl, triphenylenyl, pyrenyl, perylenyl, chrysenyl, naphthacenyl, fluoranthenyl and the like It does not. Anthryl may be 1-anthryl, 2-anthryl or 9-anthryl, and fluorenyl may be 1-fluorenyl, 2-fluorenyl Fluorenyl, 3-fluorenyl, 4-fluorenyl, and 9-fluorenyl.
본원에 사용된 용어 "헤테로아릴"은 방향족 시클릭 주쇄 원자로서 예를 들어 B, N, O, S, P(=O), Si 및 P에서 선택된 1개 이상의 헤테로 원자, 및 나머지 방향족 시클릭 주쇄 원자로서 탄소 원자를 함유하는 아릴 기를 지칭한다. 헤테로아릴은 1개 이상의 벤젠 고리와 융합된 5- 또는 6-원 모노시클릭 헤테로아릴 또는 폴리시클릭 헤테로아릴일 수 있으며, 부분적으로 포화될 수 있다. 또한 단일 결합을 통해 결합된 1개 이상의 헤테로아릴 기를 갖는 구조도 포함된다. 헤테로아릴 기는 2가 아릴 기를 포함할 수 있으며, 이것의 헤테로 원자는 산화 또는 4급화되어 N-옥사이드, 4급 염 등을 형성한다. 구체적인 예들은 모노시클릭 헤테로아릴 기, 예를 들어 푸릴, 티오페닐, 피롤릴, 이미다졸릴, 피라졸릴, 티아졸릴, 티아디아졸릴, 이소티아졸릴, 이속사졸릴, 옥사졸릴, 옥사디아졸릴, 트리아지닐, 테트라지닐, 트리아졸릴, 테트라졸릴, 푸라자닐, 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 폴리시클릭 헤테로아릴 기, 예를 들어 벤조푸라닐, 벤조티오페닐, 이소벤조푸라닐, 벤즈이미다졸릴, 벤조티아졸릴, 벤즈이소티아졸릴, 벤즈이속사졸릴, 벤족사졸릴, 이소인돌릴, 인돌릴, 인다졸릴, 벤조티아-디아졸릴, 퀴놀릴, 이소퀴놀릴, 신놀리닐, 퀴나졸리닐, 퀴녹살리닐, 카르바졸릴, 페난트리디닐 및 벤조디옥솔릴, 및 대응하는 N-옥사이드(예를 들어, 피리딜 N-옥사이드, 퀴놀릴 N-옥사이드) 및 이들의 4급 염을 포함하나 이에 한정되지 않는다.The term "heteroaryl ", as used herein, refers to an aromatic cyclic backbone atom having one or more heteroatoms selected, for example, from B, N, O, S, P (= O) Quot; refers to an aryl group containing a carbon atom as an atom. Heteroaryl may be a 5- or 6-membered monocyclic heteroaryl or polycyclic heteroaryl fused to one or more benzene rings and may be partially saturated. Also included are structures having one or more heteroaryl groups bonded through a single bond. The heteroaryl group may include a divalent aryl group, and the hetero atom of the heteroaryl group may be oxidized or quaternized to form an N-oxide, a quaternary salt, or the like. Specific examples include monocyclic heteroaryl groups such as furyl, thiophenyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, thiadiazolyl, isothiazolyl, isoxazolyl, oxazolyl, oxadiazolyl, Triazinyl, tetrazinyl, triazolyl, tetrazolyl, furazanyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, polycyclic heteroaryl groups such as benzofuranyl, benzothiophenyl, isobenzofuranyl , Benzothiazolyl, benzisothiazolyl, benzisoxazolyl, benzoxazolyl, isoindolyl, indolyl, indazolyl, benzothiadiazolyl, quinolyl, isoquinolyl, (Such as pyridyl N-oxide, quinolyl N-oxide), and quaternary salts thereof, can be converted to the corresponding N-oxides, But is not limited thereto.
치환기의 예는 다음을 포함한다: 중수소, 할로겐, 할로겐 치환기 함유 또는 무함유 (C1-C30)알킬, (C6-C30)아릴, (C6-C30)아릴 치환기 함유 또는 무함유 (C3-C30)헤테로아릴, 예를 들어 B, N, O, S, P(=O), Si 및 P에서 선택된 1개 이상의 헤테로 원자를 함유한 5- 내지 7-원 헤테로시클로알킬, 1개 이상의 방향족 고리와 융합된 5- 내지 7-원 헤테로시클로알킬, (C3-C30)시클로알킬, 1개 이상의 방향족 고리와 융합된 (C6-C30)시클로알킬, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 아다만틸, (C7-C30)비시클로알킬, (C2-C30)알케닐, (C2-C30) 알키닐, 시아노, 카르바졸릴, NR21R22, BR23R24, PR25R26, P(=O)R27R28(여기에서 R21 내지 R28은 독립적으로 (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴을 나타냄), (C6-C30)아르(C1-C30)알킬, (C1-C30)알킬(C6-C30)아릴, (C1-C30)알킬옥시, (C1-C30)알킬티오, (C6-C30)아릴옥시, (C6-C30)아릴티오, (C1-C30)알콕시카르보닐, (C1-C30)알킬카르보닐, (C6-C30)아릴카르보닐, (C6-C30)아릴옥시카르보닐, (C1-C30)알콕시카르보닐옥시, (C1-C30)알킬카르보닐옥시, (C6-C30)아릴카르보닐옥시, (C6-C30)아릴옥시카르보닐옥시, 카르복실, 니트로 및 히드록실, 또는 인접한 치환기가 함께 연결되어 고리를 형성하는 것.(C6-C30) aryl, (C6-C30) aryl substituent-containing or non-containing (C3-C30) heteroaromatic groups containing one or more heteroatoms selected from deuterium, halogen, halogen substituted or unsubstituted 5- to 7-membered heterocycloalkyl containing one or more heteroatoms selected from aryl, for example B, N, O, S, P (= O), Si and P, (C3-C30) cycloalkyl, (C6-C30) cycloalkyl fused with one or more aromatic rings, tri (C1-C30) alkylsilyl, di (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, adamantyl, (C7-C30) bicycloalkyl, (C2-C30) alkenyl, carbazolyl, NR 21 R 22, BR 23 R 24, PR 25 R 26, P (= O) R 27 R 28 ( where R 21 to R 28 are independently selected from (C1-C30) alkyl, (C6-C30) (C1-C30) alkyl (C6-C30) aryl, (C1-C30) (C6-C30) arylthio, (C1-C30) alkoxycarbonyl, (C1-C30) alkylcarbonyl, (C6-C30) alkylthio, (C6-C30) arylcarbonyloxy, (C6-C30) aryloxycarbonyl, (C1-C30) alkoxycarbonyloxy, Oxycarbonyloxy, carboxyl, nitro and hydroxyl, or adjacent substituents joined together to form a ring.
실험Experiment
시약 및 시험 방법Reagents and Test Methods
모든 용매 및 시약을 상업적으로 입수 가능한 퓨럼(purum), 퓨리스(puriss) 또는 p.a. 등급으로 입수하였다. 건조 용매는 사내 정제/분배 시스템(헥산, 톨루엔, 테트라히드로푸란 및 디에틸 에테르)으로부터 수득하거나 Sigma-Aldrich에서 구입하였다. 수분 민감성 화합물을 사용하는 모든 실험은 질소 대기하에 또는 글러브박스에서 오븐 건조된 유리 기구에서 수행하였다. 반응을 예비 코팅된 알루미늄 판(VWR 60 F254) 상의 분석용 박층 크로마토그래피(TLC)로 모니터링하고, UV 광 및/또는 과망간산칼륨 염색으로 시각화하였다. 플래쉬 크로마토그래피는 GRACERESOLV 카트리지를 사용하는 ISCO COMBIFLASH 시스템상에서 수행하였다.All solvents and reagents are commercially available from purum, puriss or p.a. Respectively. Dry solvents were obtained from an in-house refining / dispensing system (hexane, toluene, tetrahydrofuran and diethyl ether) or purchased from Sigma-Aldrich. All experiments using moisture sensitive compounds were performed in oven-dried glassware under a nitrogen atmosphere or in a glove box. The reaction was monitored by analytical thin layer chromatography (TLC) on a precoated aluminum plate (VWR 60 F254) and visualized with UV light and / or potassium permanganate stain. Flash chromatography was performed on an ISCO COMBIFLASH system using a GRACERESOLV cartridge.
달리 기재되지 않는 경우, 1H-NMR-스펙트럼(500 MHz 또는 400 MHz)은 30℃에서 Varian VNMRS-500 또는 VNRMS-400 분광계상에서 수득했다. 화학적 이동은 다음 중 하나를 기준으로 했다: CDCl3 중의 CHCl3(δ=0.00)중의 TMS, 벤젠-d6 중의 벤젠-d5(7.15) 또는 DMSO-d6 중의 DMSO-d5(δ 2.50). 필요한 경우, 피크 할당을 COSY, HSQC 또는 NOESY 실험을 이용하여 수행하였다.Unless otherwise noted, 1 H-NMR-spectra (500 MHz or 400 MHz) were obtained on a Varian VNMRS-500 or VNRMS-400 spectrometer at 30 ° C. Chemical shifts were based on one of the following: TMS in CHCl3 (delta = 0.00) in CDCl3, benzene-d5 (7.15) in benzene-d6 or DMSO-d5 (delta 2.50) in DMSO-d6. Peak assignments were performed using the COZY, HSQC or NOESY experiments, if necessary.
Varian VNMRS-500 또는 VNRMS-400 분광계에서 13C 스펙트럼(125 MHz 또는 100MHz)을 수득하였다(용매 또는 표준물 신호: 0.0 - CDCl3 중의 TMS, 128.02 - 벤젠-d6, 39.43 - DMSO - d6).13C spectra (125 MHz or 100 MHz) were obtained on a Varian VNMRS-500 or VNRMS-400 spectrometer (solvent or standard signal: TMS in 0.0-CDCl3, 128.02-benzene-d6, 39.43-DMSO-d6).
통상의 LC/MS 연구를 하기와 같이 수행하였다. 시료의 5 마이크로리터 분취액을 "THF 중의 3 mg/ml 용액"으로서, PI 모드로 작동하는 이중 스프레이 일렉트로스프레이 인터페이스(ESI)를 통해 AGILENT 6520 QTof(사중극자-비행 시간형) MS 시스템에 커플링된 AGILENT 1200SL 이원 구배 액체 크로마토그래피 상에 주입하였다. 하기 분석 조건을 사용하였다: 칼럼: 150 x 4.6 mm ID 3.5 ㎛ ZORBAX SB-C8; 칼럼 온도: 40℃; 이동상: 40분에서 75/25 A/B 내지 15/85 A/B; 용매 A = 물 중의 0.1 부피% 포름산; 용액 B = THF; 유량 1.0 mL/min; UV 검출: 다이오드 배열 210 내지 600 nm (추출된 파장 250, 280 nm); ESI 조건: 기체 온도 365℃; 기체 유량 - 8 ml/min; 모세관 - 3.5 kV; 네뷸라이저 - 40PSI; 프래그멘터(fragmentor) -145 V.A typical LC / MS study was performed as follows. A 5 microliter aliquot of the sample was coupled to the AGILENT 6520 QTof (quadrupole-time-of-flight) MS system via a double spray electrospray interface (ESI) operating in PI mode as a "3 mg / ml solution in THF" Gt; AGILENT < / RTI > 1200 SL binary gradient liquid chromatography. The following assay conditions were used: Column: 150 x 4.6 mm ID 3.5 mu m ZORBAX SB-C8; Column temperature: 40 占 폚; Mobile phase: 75/25 A / B to 15/85 A / B at 40 minutes; Solvent A = 0.1% by volume formic acid in water; Solution B = THF; Flow rate 1.0 mL / min; UV detection: Diode array 210 to 600 nm (extracted wavelength 250, 280 nm); ESI conditions: gas temperature 365 DEG C; Gas flow rate - 8 ml / min; Capillary - 3.5 kV; Nebulizer - 40PSI; Fragmenter-145 V.
순환 전압전류법 측정은 WaveNano 정전위기(Pine Research Instrumentation)를 사용하여 수행하였다. 지지 전해질인 0.1 M TBAP를 갖는 은/질산은(무수 아세토니트릴 중의 5 mM 질산은의 새로 제조된 용액에 침지된 은 와이어), 플래티넘 와이어, 및 플래티넘 디스크(1.6 mm 직경)를 각각 기준 전극, 상대 전극 및 작동 전극으로 사용하였다. 지지 전해질인 1M TBAP를 함유한 DCM(무수화물)중 약 5 mM의 분석물 용액에 대해 모든 산화 스캔을 행했고; 0.1 M TBAP를 함유한 THF(무수물, 억제제 무함유)중 5 mM 용액에 대해 모든 환원 스캔을 행했다. 전형적으로 3번의 사이클(6 세그멘트)을 20 mV/s의 스윕 속도(sweep rate)에서 수행했다. 에너지 준위를 4.7 V의 오프셋으로 보정하여 진공 준위로 전환하였다.Cyclic voltammetry measurements were performed using a WaveNano electrostatic cascade (Pine Research Instrumentation). (Silver wire immersed in a freshly prepared solution of 5 mM silver nitrate in anhydrous acetonitrile), platinum wire, and a platinum disk (1.6 mm diameter) with 0.1 M TBAP as a supporting electrolyte were added to the reference electrode, And used as a working electrode. All oxidation scans were performed on approximately 5 mM of the analyte solution in DCM (anhydrous) containing the supporting electrolyte 1M TBAP; All reduction scans were performed on 5 mM solutions in THF (anhydrous, inhibitor free) containing 0.1 M TBAP. Three cycles (6 segments) were typically run at a sweep rate of 20 mV / s. The energy level was corrected to an offset of 4.7 V and converted to a vacuum level.
DSC는 모든 사이클에서 질소 대기 하에 10℃/min의 스캔 속도로 2000 인스트루먼트를 사용하여 수행하였다. 시료(약 7 내지 10 mg)를 상온에서 300℃까지 스캔하고, -60℃로 냉각시킨 뒤, 300℃까지 재가열했다. 유리 전이 온도(Tg)를 제2 가열 스캔상에서 측정했다. 데이터 분석을 TA Universal Analysis 소프트웨어를 사용하여 수행했다. Tg는 "변곡점의 중점" 방법을 사용하여 계산했다.DSC was performed using a 2000 instrument at a scan rate of 10 [deg.] C / min under a nitrogen atmosphere in all cycles. The sample (about 7 to 10 mg) was scanned from room temperature to 300 캜, cooled to -60 캜, and reheated to 300 캜. The glass transition temperature (T g ) was measured on a second heat scan. Data analysis was performed using TA Universal Analysis software. T g was calculated using the "center of inflection point" method.
모델링modelling
모든 계산은 Gaussian09 프로그램1을 사용하였다. 계산은 혼성 밀도 함수 이론(DFT) 방법인 B3LYP2, 및 6-31G* (5d) 기저계(basis set)3로 수행하였다. 일중항 상태 계산은 폐각 근사법(closed shell approximation)을 사용했고, 삼중항 상태 계산은 개각 근사법(open shell approximation)을 사용했다. 모든 값은 전자볼트(eV) 단위로 나타냈다. HOMO 및 LUMO 수치를 일중항 기저 상태의 최적화된 기하구조의 오비탈 에너지로부터 측정하였다. 삼중항 에너지를 최적화된 삼중항 상태와 최적화된 일중항 상태의 총 에너지 사이의 차이로 측정하였다.All calculations were performed using Gaussian09 program 1 . The calculations were performed with the hybrid density function theory (DFT) method B3LYP 2 , and 6-31G * (5d) basis set 3 . The singlet condition calculation uses a closed shell approximation and the triplet condition calculation uses an open shell approximation. All values are expressed in electron volts (eV). The HOMO and LUMO values were measured from the orbital energies of the optimized geometry of the singlet ground state. Triplet energy was measured as the difference between the optimized triplet state and the total energy of the optimized singlet state.
1. Gaussian 09, Revision A.02, Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H.P.; Izmaylov, A.F.; Bloino, J.; Zheng, G.; Sonnenberg, J.L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, N.; Vreven, T.; Montgomery, Jr., J.A.; Peralta, J.E.; Ogliaro, F.; Bearpark, M.; Heyd, J.J.; Brothers, E.; Kudin, K.N.; Staroverov, V.N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J.C.; Iyengar, S.S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J.M.; Klene, M.; Knox, J.E.; Cross, J.B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R.E.; Yazyev, O.; Austin, A.J.; Cammi, R.; Pomelli, C.; Ochterski, J.W.; Martin, R.L.; Morokuma, K.; Zakrzewski, V.G.; Voth, G.A.; Salvador, P.; Dannenberg, J.J.; Dapprich, S.; Daniels, A.D.; Farkas, O.; Foresman, J.B.; Ortiz, J.V.; Cioslowski, J.; Fox, D.J., Gaussian, Inc., Wallingford CT, 2009.1. Gaussian 09, Revision A.02, Frisch, M. J .; Trucks, G. W .; Schlegel, H. B .; Scuseria, G. E .; Robb, M. A .; Cheeseman, J. R .; Scalmani, G .; Barone, V .; Mennucci, B .; Petersson, G. A .; Nakatsuji, H .; Caricato, M .; Li, X .; Hratchian, H. P .; Izmaylov, A. F .; Bloino, J .; Zheng, G .; Sonnenberg, J. L .; Hada, M .; Ehara, M .; Toyota, K .; Fukuda, R .; Hasegawa, J .; Ishida, M .; Nakajima, T .; Honda, Y .; Kitao, O .; Nakai, N .; Vreven, T .; Montgomery, Jr., J.A .; Peralta, J. E .; Ogliaro, F .; Bearpark, M .; Heyd, J.J .; Brothers, E .; Kudin, K. N .; Staroverov, V. N .; Kobayashi, R .; Normand, J .; Raghavachari, K .; Rendell, A .; Burant, J. C .; Iyengar, S. S .; Tomasi, J .; Cossi, M .; Rega, N .; Millam, J. M .; Klene, M .; Knox, J. E .; Cross, J.B .; Bakken, V .; Adamo, C .; Jaramillo, J .; Gomperts, R .; Stratmann, R. E .; Yazyev, O .; Austin, A. J .; Cammi, R .; Pomelli, C .; Ochterski, J. W .; Martin, R. L .; Morokuma, K .; Zakrzewski, V. G .; Voth, G. A .; Salvador, P .; Dannenberg, J. J.; Dapprich, S .; Daniels, A.D .; Farkas, O .; Foresman, J.B .; Ortiz, J. V .; Cioslowski, J .; Fox, D. J., Gaussian, Inc., Wallingford CT, 2009.
2. (a) Becke, A.D. J. Chem . Phys . 1993, 98, 5648. (b) Lee, C.; Yang, W.; Parr, R.G. Phys. Rev B 1988, 37, 785. (c) Miehlich, B.; Savin, A.; Stoll, H.; Preuss, H. Chem . Phys . Lett . 1989, 157, 200.2. (a) Becke, AD J. Chem . Phys . 1993 , 98 , 5648. (b) Lee, C .; Yang, W .; Parr, RG Phys. Rev B 1988 , 37 , 785. (c) Miehlich, B .; Savin, A .; Stoll, H .; Preuss, H. Chem . Phys . Lett . 1989 , 157 , 200.
3. (a) Ditchfield, R.; Hehre, W.J.; Pople, J.A. J. Chem . Phys . 1971, 54, 724. (b) Hehre, W.J.; Ditchfield, R.; Pople, J.A. J. Chem . Phys . 1972, 56, 2257. (c) Gordon, M.S. Chem . Phys . Lett. 1980, 76, 163.3. (a) Ditchfield, R .; Hehre, WJ; Pople, JA J. Chem . Phys . 1971 , 54 , 724. (b) Hehre, WJ; Ditchfield, R .; Pople, JA J. Chem . Phys . 1972 , 56 , 2257. (c) Gordon, MS Chem . Phys . Lett. 1980 , 76 , 163.
4-(2,8-디메틸-5-(p-4- (2,8-dimethyl-5- (p- 톨릴Tolyl )) 페노포스파지닌Pennosphospinine -10(5H)-일)-N,N--10 (5H) -yl) -N, N- 디페닐아닐린의Of diphenyl aniline 제조 Produce
250 mL 슐렝크(Schlenk) 플라스크를 2-브로모-N-(2-브로모-4-메틸페닐)-4-메틸-N-(p-톨릴)아닐린(3.00 g, 6.74 mmol) 및 100 mL 디에틸 에테르로 충전했다. 연황색 용액을 -78℃로 냉각시키고, 15분 초과의 시간 동안 n-BuLi(8.42 mL, 13.5 mmol)을 적가하였다. 이 온도에서 1시간 동안 교반한 후, 15분 초과의 시간 동안 4-(디클로로포스피노)-N,N-디페닐아닐린(2.33 g, 6.74 mmol)의 THF 용액 30 mL를 적가하였다. 용액을 천천히 상온으로 가온하고 밤새 교반하였다. 용매를 회전 증발(rotary evaporation)로 제거하고, 잔류물을 100 mL CH2Cl2에 녹였다. 유기 층을 염수(3×100 mL)로 수 차례 세척한 후, MgSO4로 건조시켰다. 셀라이트(Celite)를 통해 여과시킨 후, 용액을 회전 증발로 제거하고, 잔류물을 EtOH로부터 재결정화시켰다.A 250 mL Schlenk flask was charged with 2-bromo-N- (2-bromo-4-methylphenyl) -4-methyl-N- (p- tolyl) aniline (3.00 g, 6.74 mmol) Ethyl ether. The light yellow solution was cooled to -78 < 0 > C and n- BuLi (8.42 mL, 13.5 mmol) was added dropwise over a period of 15 min. After stirring at this temperature for 1 h, 30 mL of a THF solution of 4- (dichlorophosphino) -N, N-diphenyl aniline (2.33 g, 6.74 mmol) was added dropwise over a period of 15 min. The solution was slowly warmed to room temperature and stirred overnight. The solvent was removed by rotary evaporation and the residue was dissolved in 100 mL CH 2 Cl 2 . After washing several times, the organic layer with brine (3 × 100 mL), dried over MgSO 4. After filtration through Celite, the solution was removed by rotary evaporation and the residue was recrystallized from EtOH.
1 H NMR (400 MHz , CDCl 3 ) δ 2.32 (s, 6H), 2.53 (s, 3H), 6.42 (dd, J = 4, 8 Hz, 2H), 6.98 (dd, J = 4, 8 Hz, 2H), 7.07 (m, 4H), 7.16 (t, J = 8 Hz, 4H), 7.35 (t, J = 8 Hz, 4H), 7.45-7.53 (m, 4H), 7.65 (dd, J = 4, 8 Hz, 2H). 1 H NMR (400 MHz, CDCl 3) δ 2.32 (s, 6H), 2.53 (s, 3H), 6.42 (dd, J = 4, 8 Hz, 2H), 6.98 (dd, J = 4, 8 Hz, J = 8 Hz, 4H), 7.45-7.53 (m, 4H), 7.65 (dd, J = , 8 Hz, 2H).
13 C{ 1 H} NMR ( CDCl 3 ) δ 20.5, 21.7, 113.3, 114.9, 117.2(d, J = 12 Hz), 121.4 (d, J = 16 Hz), 124.9, 125.2, 127.2, 130.0, 132.2 (d, J = 16 Hz), 130.9, 131.6 (d, J = 10 Hz), 132.6, 134.0 (d, J = 18 Hz), 135.2, 139.3 (d, J = 30 Hz), 143.6, 146.9, 150.9. 13 C {1 H} NMR ( CDCl 3) δ 20.5, 21.7, 113.3, 114.9, 117.2 (d, J = 12 Hz), 121.4 (d, J = 16 Hz), 124.9, 125.2, 127.2, 130.0, 132.2 ( d, J = 16 Hz), 130.9,131.6 (d, J = 10 Hz), 132.6,134.0 (d, J = 18 Hz), 135.2, 139.3 (d, J = 30 Hz), 143.6, 146.9, 150.9.
31 P{ 1 H} NMR ( CDCl 3 ) δ -0.3. 31 P {1 H} NMR ( CDCl 3) δ -0.3.
승화 후 순도 (LC-MS): 97.2%. 계산치: HOMO: -5.10; LUMO: -0.60. Purity after sublimation (LC-MS): 97.2%. Calculated: HOMO: -5.10; LUMO: -0.60.
10-(4-(10- (4- ( 디페닐아미노Diphenylamino )) 페닐Phenyl )-2,8-디메틸-5-(p-) -2, 8-dimethyl-5- (p- 톨릴Tolyl )-5,10-) -5,10- 디히드로Dihydro -- 페노포스파지닌Pennosphospinine 10- 10- 옥사이드의Oxide 제조 Produce
상기 제조된 4-(2,8-디메틸-5-(p-톨릴)페노포스파지닌-10(5H)-일)-N,N-디페닐아닐린의 CH2Cl2(50 mL) 용액에 H2O2 30% 수용액(5 mL)을 첨가하였다. 2상 혼합물을 상온에서 밤새 교반한 후, 5 mL 물을 첨가하였다. 유기 분획을 분리하고, MgSO4로 건조시킨 후, 용매를 회전 증발로 제거하였다. 잔류물을 에틸 아세테이트/헥산(1:1)에 녹이고, 실리카 플러그를 통해 여과시켰다. 유기 용매를 회전 증발로 제거하고, 잔류물을 CH2Cl2/헥산으로부터 재결정화시켜 백색 고체를 얻었다(질량 = 1.82 g, 58.9%), Tg = 123.5℃.To a solution of the prepared 4- (2,8-dimethyl-5- (p-tolyl) phenopospazin-10 (5H) -yl) -N, N-diphenyl aniline in CH 2 Cl 2 H 2 O 2 30% aqueous solution (5 mL) was added. The biphasic mixture was stirred at room temperature overnight, then 5 mL of water was added. After separating the organic fraction, dried over MgSO 4, the solvent was removed by rotary evaporation. The residue was dissolved in ethyl acetate / hexane (1: 1) and filtered through a silica plug. The organic solvent was removed by rotary evaporation and the residue was recrystallized from CH 2 Cl 2 / hexanes to give a white solid (mass = 1.82 g, 58.9%), T g = 123.5 ° C.
1 H NMR (400 MHz , CDCl 3 ) δ 2.27 (s, 6H), 2.51 (s, 3H), 6.38 (dd, J = 4, 8 Hz, 2H), 7.01 (dd, J = 4, 8 Hz, 2H), 7.06 (m, 4H), 7.15 (t, J = 8 Hz, 4H), 7.28 (t, J = 8 Hz, 4H), 7.43-7.51 (m, 4H), 7.62 (dd, J = 4, 8 Hz, 2H). 1 H NMR (400 MHz, CDCl 3) δ 2.27 (s, 6H), 2.51 (s, 3H), 6.38 (dd, J = 4, 8 Hz, 2H), 7.01 (dd, J = 4, 8 Hz, 2H), 7.06 (m, 4H), 7.15 (t, J = 8 Hz, 4H), 7.28 (t, J = 8 Hz, 4H), 7.43-7.51 , 8 Hz, 2H).
13 C{ 1 H} NMR ( CDCl 3 ) δ 20.3, 21.3, 113.1, 114.2, 116.7 (d, J = 9 Hz), 120.0 (d, J = 18 Hz), 124.2, 124.9, 127.7, 129.4, 129.9 (d, J = 14 Hz), 130.3, 131.4 (d, J = 9 Hz), 131.8, 132.6 (d, J = 18 Hz), 133.2, 138.6 (d, J = 25 Hz), 142.9, 146.7, 150.2. 13 C {1 H} NMR ( CDCl 3) δ 20.3, 21.3, 113.1, 114.2, 116.7 (d, J = 9 Hz), 120.0 (d, J = 18 Hz), 124.2, 124.9, 127.7, 129.4, 129.9 ( (d, J = 14 Hz), 130.3, 131.4 (d, J = 9 Hz), 131.8, 132.6 (d, J = 18 Hz), 133.2, 138.6 (d, J = 25 Hz), 142.9,
31 P{ 1 H} NMR ( CDCl 3 ) δ 6.4. 31 P {1 H} NMR ( CDCl 3) δ 6.4.
Tg = 123.5℃. 승화 후 순도(LC-MS): 96.8%. 계산치: HOMO: -5.04; LUMO: -0.65.T g = 123.5 ℃. Purity (LC-MS) after sublimation: 96.8%. Calculated: HOMO: -5.04; LUMO: -0.65.
이러한 화합물들은 OLED 장치용 필름 층으로 사용될 수 있다.These compounds can be used as film layers for OLED devices.
Claims (15)
A)
(여기에서, 화학식 A 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소 또는 치환된 탄화수소이고,
여기에서, 선택적으로 R2, R3, R4, R5, R6, R7, R8, R9 및 R10에서 선택된 2개 이상의 R 기는 1개 이상의 고리 구조를 형성할 수 있음);
B)
(여기에서, 화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 탄화수소 또는 치환된 탄화수소이고,
여기에서, 선택적으로 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10에서 선택된 2개 이상의 R 기는 1개 이상의 고리 구조를 형성할 수 있음); 또는
C) 이들의 조합.A composition comprising at least one compound selected from the following compounds:
A)
Wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 are each independently a hydrocarbon or a substituted hydrocarbon,
Wherein two or more R groups optionally selected from R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 may form one or more ring structures;
B)
(Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are each independently a hydrocarbon or a substituted hydrocarbon,
Wherein two or more R groups optionally selected from R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 may form one or more ring structures; or
C) a combination of these.
화학식 B 중 R1, R2, R3, R4, R5, R6, R7, R8, R9 및 R10은 각각 독립적으로 수소, 알킬, 치환된 알킬, 아릴, 치환된 아릴, 헤테로아릴 또는 치환된 헤테로아릴인 조성물.A compound according to claim 1, wherein R1, R2, R3, R4, R5, R6, R7, R9 and R10 in formula A are each independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl or substituted hetero Aryl,
Wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9 and R 10 in Formula B are each independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl.
, , , The composition of claim 1, wherein the at least one compound is selected from the following compounds, or combinations thereof.
, , ,
9. The composition of claim 8, wherein the at least one compound is the following compound.
12. The composition of claim 11, wherein the at least one compound is selected from the following compounds.
14. An electronic device comprising at least one element formed from the composition of any one of claims 1 to 13.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261740903P | 2012-12-21 | 2012-12-21 | |
US61/740,903 | 2012-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20140081694A true KR20140081694A (en) | 2014-07-01 |
Family
ID=50950048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130157818A KR20140081694A (en) | 2012-12-21 | 2013-12-18 | Phenophosphazines compounds |
Country Status (4)
Country | Link |
---|---|
JP (2) | JP6474958B2 (en) |
KR (1) | KR20140081694A (en) |
CN (1) | CN103880886A (en) |
TW (1) | TWI606056B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150037626A (en) * | 2013-09-30 | 2015-04-08 | 주식회사 엘지화학 | Heterocyclic compound and organic light emitting device using the same |
US11271168B2 (en) | 2017-02-17 | 2022-03-08 | Samsung Display Co., Ltd. | Heterocyclic compound and organic light-emitting device including the same |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102547685B1 (en) * | 2016-02-22 | 2023-06-27 | 삼성디스플레이 주식회사 | Organic light emitting device |
CN110205117A (en) * | 2019-06-11 | 2019-09-06 | 武汉华星光电半导体显示技术有限公司 | Phenyl phosphorus oxygen thermal activation delayed fluorescence material and its synthetic method, electroluminescent device |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3354214A (en) * | 1964-09-15 | 1967-11-21 | Tamborski Christ | 5-lower-alkyl-10-phenyl-5, 10-dihydrophenophosphazine compounds |
JP2830292B2 (en) * | 1990-02-01 | 1998-12-02 | 松下電器産業株式会社 | Vehicle heater unit |
JP3226984B2 (en) * | 1992-09-21 | 2001-11-12 | 第一工業製薬株式会社 | New reactive flame retardant for polyester resin |
WO2008063583A1 (en) * | 2006-11-17 | 2008-05-29 | Polyera Corporation | Acene-based organic semiconductor materials and methods of preparing and using the same |
JP5659819B2 (en) * | 2011-01-24 | 2015-01-28 | コニカミノルタ株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE |
JP5724588B2 (en) * | 2011-04-28 | 2015-05-27 | コニカミノルタ株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE |
JP5782836B2 (en) * | 2011-05-27 | 2015-09-24 | コニカミノルタ株式会社 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, AND COMPOUND |
CN102850622B (en) * | 2012-08-13 | 2014-07-30 | 华南理工大学 | Organic halogen-free flame-retardant silane cross-linked polyethylene and its preparation method and composition |
CN102827409B (en) * | 2012-08-13 | 2014-07-30 | 华南理工大学 | Halogen-free flame-retardant organosilane cross-linked polyethylene, and preparation method and composition thereof |
-
2013
- 2013-11-29 TW TW102143834A patent/TWI606056B/en not_active IP Right Cessation
- 2013-12-18 KR KR1020130157818A patent/KR20140081694A/en unknown
- 2013-12-20 JP JP2013263134A patent/JP6474958B2/en not_active Expired - Fee Related
- 2013-12-20 CN CN201310712949.XA patent/CN103880886A/en active Pending
-
2018
- 2018-09-28 JP JP2018184959A patent/JP2019038810A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150037626A (en) * | 2013-09-30 | 2015-04-08 | 주식회사 엘지화학 | Heterocyclic compound and organic light emitting device using the same |
US11271168B2 (en) | 2017-02-17 | 2022-03-08 | Samsung Display Co., Ltd. | Heterocyclic compound and organic light-emitting device including the same |
Also Published As
Publication number | Publication date |
---|---|
JP2014139167A (en) | 2014-07-31 |
TW201427988A (en) | 2014-07-16 |
TWI606056B (en) | 2017-11-21 |
JP2019038810A (en) | 2019-03-14 |
CN103880886A (en) | 2014-06-25 |
JP6474958B2 (en) | 2019-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6640189B2 (en) | Composition containing benzocyclobutene-substituted carbazole and electronic device containing the same | |
JP2013211550A (en) | Charge transport layers and films containing the same | |
JP2019048812A (en) | Phenoxaphosphine compound | |
JP2019038810A (en) | Phenophosphazine compound | |
US20160248020A1 (en) | Compositions containing fluorene substituted triazine derived compounds, and electronic devices containing the same | |
EP3240856B1 (en) | Fluorene derivatives as light emitting elements for electroluminescent devices | |
Yin et al. | Benzobisoxazole-based electron transporting materials with high T g and ambipolar property: high efficiency deep-red phosphorescent OLEDs | |
JP6349083B2 (en) | Quinoline-benzoxazole-derived compounds for electronic thin films and electronic devices | |
US10103334B2 (en) | Compositions with triarylamine derivatives and OLED device containing the same | |
KR102422937B1 (en) | Spiroacridine derivatives useful as OLEDs | |
US9966537B2 (en) | Compositions with 2,3-disubstituted indoles as charge transport materials, and display devices fabricated therefrom | |
Annaka et al. | Synthesis and Photophysical Properties of Extended π-Conjugative and Push–Pull-Type 1, 4-Diaryl-1-thio-1, 3-butadienes Incorporated in a Dibenzobarrelene Skeleton | |
JP2012051855A (en) | Organic compound and organic light-emitting device using the same |